Lung Therapeutics, Inc. is a pharmaceutical company targeting niche, orphan drug indications for lung injury and disease, with an emphasis on fibrosis.
Current efforts are focused on a severe complication of pneumonia, called loculated pleural effusion, a debilitating condition where fluid has built up in the chest cavity surrounding the lungs and fibrinous scar tissue in the pleural cavity blocks fluid drainage. Our first product, LTI-01 (single chain urokinase plasminogen activator, or scuPA), is being studied for safe clearance of fibrinous sc
Operating as usual
Timeline photos
Timeline photos
Timeline photos
Lung Therapeutics breathes easy with $14M Series B | FierceBiotech Texas startup Lung Therapeutics has got off a $14.3 million Series B round as it eyes the cash boost for its trials in fibrosis, lung injury and disease.
Lung Therapeutics, Inc. Doses First Patient in Phase 1 Clinical Trial of LTI-01 in Australia and New Zealand AUSTIN, Texas, March 14, 2017 /PRNewswire/ -- Lung Therapeutics, Inc., a clinical stage pharmaceutical company...
Over 25 years of research has gone into our lung treatment solutions. At Lung Therapeutics, we won't stop until we have the answer.
Lung Therapeutics, Inc. Lung Therapeutics, Inc. is a pharmaceutical company targeting niche, orphan drug indications for lung injury and disease, with an emphasis on fibrosis.
More great news from Lung Therapeutics with NIH funding for Phase 1A/1B Clinical Trial: http://www.lungtx.com/lung-therapeutics-inc-chief-scientific-officer-dr-steven-idell-receives-nih-grant-phase-1a1b-0
Lung Therapeutics, Inc. Chief Scientific Officer Dr. Steven Idell Receives NIH Grant for Phase... Lung Therapeutics, Inc. Chief Scientific Officer Dr. Steven Idell Receives NIH Grant for Phase 1A/1B Clinical Trial of Drug Candidate LTI-01
Untitled Album
Monday | 9am - 5pm |
Tuesday | 9am - 5pm |
Wednesday | 9am - 5pm |
Thursday | 9am - 5pm |
Friday | 9am - 5pm |
Bloodborne Pathogen Training is the leader in user friendly, OSHA compliant, online bloodborne pathogens training for anyone who may come in contact with blood.
MicroBasics is an innovative company dedicated to animal health, nutrition, and food safety. Our products harness the infinite discoveries found in nature.
BioAustin is here to serve all in the central Texas life science community in advancing the growth and development of our industry.
The Texas Healthcare & Bioscience Institute (THBI) is the leading voice of the Texas Healthcare Bioscience Industry.
At Senseye we are dedicated to finding non-invasive techniques to measure human cognitive and emotional states
We lead the delivery of nanotechnology-powered innovations to heal the world and enable safe, smart lives.
We entering a world of longevity, thank you God is with us and our intelligence lies co-supporting our structure.
InSyBio has developed an on-line suite of software tools – called InSyBio Suite – which assists biology researchers in extracting valuable biological knowledge from experimental data.
Wet lab and startup incubator in Austin, TX. Our companies are centered in the life sciences. Even though we are part of Austin Community College, any company can apply. http://sites.austincc.edu/incubator/apply/